HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 614 filers reported holding HORIZON THERAPEUTICS PUB L in Q1 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $45,944,900 | +73.2% | 403,734 | -5.8% | 0.70% | +53.7% |
| Q3 2022 | $26,532,000 | -24.8% | 428,706 | -3.1% | 0.45% | -16.2% |
| Q2 2022 | $35,288,000 | -20.6% | 442,431 | +4.8% | 0.54% | -4.4% |
| Q1 2022 | $44,418,000 | +55.2% | 422,183 | +58.9% | 0.57% | +68.8% |
| Q4 2021 | $28,625,000 | -2.6% | 265,634 | -1.0% | 0.34% | -7.9% |
| Q3 2021 | $29,396,000 | +9.5% | 268,362 | -6.4% | 0.36% | +14.8% |
| Q2 2021 | $26,852,000 | -32.1% | 286,763 | -33.3% | 0.32% | -34.8% |
| Q1 2021 | $39,546,000 | -10.8% | 429,664 | -29.1% | 0.49% | -14.4% |
| Q4 2020 | $44,354,000 | -22.4% | 606,345 | -17.6% | 0.57% | -44.6% |
| Q3 2020 | $57,130,000 | +14.4% | 735,449 | -18.1% | 1.03% | +40.0% |
| Q2 2020 | $49,934,000 | +17.4% | 898,413 | -37.4% | 0.74% | +10.9% |
| Q1 2020 | $42,541,000 | -31.1% | 1,436,234 | -15.7% | 0.66% | +3.4% |
| Q4 2019 | $61,707,000 | +21.1% | 1,704,601 | -8.9% | 0.64% | +16.3% |
| Q3 2019 | $50,959,000 | +24.8% | 1,871,412 | +10.2% | 0.55% | +26.4% |
| Q2 2019 | $40,846,000 | – | 1,697,674 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |